Technology
SS&C Technologies Releases Q3 2024 Earnings Results
Published
3 months agoon
By
Q3 2024 GAAP revenue $1,465.8 million, up 7.3%, Fully Diluted GAAP Earnings Per Share $0.65, up 6.6%
Record Adjusted revenue $1,466.8 million, up 7.3%, Adjusted Diluted Earnings Per Share $1.29, up 10.3%
WINDSOR, Conn., Oct. 24, 2024 /PRNewswire/ — SS&C Technologies Holdings, Inc. (NASDAQ: SSNC), a global provider of investment, financial and healthcare software and software-enabled services, today announced its financial results for the third quarter ended September 30, 2024.
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in millions, except per share data):
2024
2023
Change
2024
2023
Change
GAAP Results
Revenue
$1,465.8
$1,365.9
7.3 %
$4,352.3
$4,091.2
6.4 %
Operating income
325.1
306.4
6.1 %
985.6
874.7
12.7 %
Operating income margin
22.2 %
22.4 %
-20 bps
22.6 %
21.4 %
120 bps
Diluted earnings per share attributable to
SS&C
$0.65
$0.61
6.6 %
$2.02
$1.62
24.7 %
Net income attributable to SS&C
164.4
156.0
5.4 %
512.3
412.7
24.1 %
Adjusted Non-GAAP Results (defined in Notes 1 – 4 below)
Adjusted revenue
$1,466.8
$1,366.7
7.3 %
$4,355.0
$4,093.5
6.4 %
Adjusted operating income attributable to
SS&C
548.8
517.4
6.1 %
1,630.5
1,496.2
9.0 %
Adjusted operating income margin
37.4 %
37.9 %
-50 bps
37.4 %
36.6 %
80 bps
Adjusted diluted earnings per share
attributable to SS&C
$1.29
$1.17
10.3 %
$3.83
$3.39
13.0 %
Adjusted consolidated EBITDA attributable
to SS&C
566.2
533.9
6.0 %
1,681.9
1,545.2
8.8 %
Adjusted consolidated EBITDA margin
38.6 %
39.1 %
-50 bps
38.6 %
37.7 %
90 bps
Third Quarter 2024 Highlights:
Q3 2024 GAAP Revenue growth and Adjusted Revenue growth were 7.3 percentAdjusted Organic Revenue Growth was 6.4 percent, Financial Services Recurring Revenue Growth was 7.2 percent.Q3 2024 we bought back 1.2 million shares for $89.4 million, at an average price of $72.72 per share.SS&C reported GAAP net income attributable to SS&C of $164.4 million, up 5.4 percent and adjusted consolidated EBITDA attributable to SS&C of $566.2 million for Q3 2024, up 6.0 percent.GAAP operating income margin for Q3 2024 was 22.2 percent. Adjusted consolidated EBITDA margin for Q3 2024 was 38.6 percent.SS&C completed its acquisition of Battea-Class Action Services on September 27, 2024 for a purchase price of approximately $670 million.
“SS&C reported strong results for Q3 2024, with organic revenue up 6.4 percent, accompanied by $1.29 in adjusted earnings per share, up 10.1 percent,” says Bill Stone, Chairman and Chief Executive Officer. “A few weeks ago we hosted over 1,000 clients, prospects, and partners in New Orleans for our annual SS&C Deliver Conference. We showcased SS&C’s strengths in emerging technology, best practice operational solutions, and deep industry expertise. Feedback has been overwhelmingly positive and we look forward to another great event in Scottsdale, AZ in 2025.”
Operating Cash Flow
SS&C generated net cash from operating activities of $902.0 million for the nine months ended September 30, 2024, compared to $826.7 million for the same period in 2023, a 9.1% increase. SS&C ended the third quarter with $694.7 million in cash and cash equivalents and $7,243.1 million in gross debt. SS&C’s net debt balance as defined in our credit agreement, which excludes cash and cash equivalents of $159.0 million held at DomaniRx, LLC was $6,707.3 million as of September 30, 2024. SS&C’s consolidated net leverage ratio as defined in our credit agreement stood at 2.94 times consolidated EBITDA attributable to SS&C as of September 30, 2024. SS&C’s net secured leverage ratio stood at 1.74 times consolidated EBITDA attributable to SS&C as of September 30, 2024.
Guidance
Q4 2024
FY 2024
Adjusted Revenue ($M)
$1,460.0 – $1,500.0
$5,815.0 – $5,855.0
Adjusted Net Income attributable to SS&C
($M)
$329.0 – $345.0
$1,299.0 – $1,315.0
Interest Expense1 ($M)
$110.0 – $112.0
$442.0 – $444.0
Adjusted Diluted Earnings per Share
attributable to SS&C
$1.29 – $1.35
$5.12 – $5.18
Cash from Operating Activities ($M)
–
$1,330.0 – $1,370.0
Capital Expenditures (% of revenue)
–
4.1% – 4.5%
Diluted Shares (M)
254.6 – 255.6
253.6 – 253.8
Effective Income Tax Rate (%)
26 %
26 %
1Interest expense is net of deferred financing cost amortization and original issue discount
SS&C does not provide reconciliations of guidance for Adjusted Revenues and Adjusted Net Income to comparable GAAP measures, in reliance on the unreasonable efforts exception provided under Item 10(e)(1)(i)(B) of Regulation S-K. SS&C is unable, without unreasonable efforts, to forecast certain items required to develop meaningful comparable GAAP financial measures. These items include acquisition transactions and integration, foreign exchange rate changes, as well as other non-cash and other adjustments as defined under the Company’s Credit agreement, that are difficult to predict in advance in order to include in a GAAP estimate. The unavailable information could have a significant impact on Q4 2024 and FY 2024 GAAP financial results.
Non-GAAP Financial Measures
Adjusted revenue, adjusted operating income, adjusted consolidated EBITDA, adjusted net income and adjusted diluted earnings per share are non-GAAP measures. See the accompanying notes for the reconciliations and definitions for each of these non-GAAP measures and the reasons our management believes these measures provide useful information to investors regarding our financial condition and results of operations.
Earnings Call and Press Release
SS&C’s third quarter 2024 earnings call will take place at 5:00 p.m. eastern time today, October 24, 2024. The call will discuss third quarter 2024 results. Interested parties may dial 888-210-4650 (US and Canada) or 646-960-0327 (International), and request the “SS&C Technologies Third Quarter 2024 Earnings Conference Call”; conference ID #4673675. In connection with the earnings call, a presentation will be available on SS&C’s website at www.ssctech.com. The call will be available for replay via the webcast on SS&C’s website; access: https://investor.ssctech.com/financials/quarterly-results/default.aspx
Certain information contained in this press release relating to, among other things, the Company’s financial guidance for the fourth quarter and full year of 2024 constitute forward-looking statements for purposes of the safe harbor provisions under the Private Securities Litigation Reform Act of 1995. Forward-looking statements include statements concerning plans, objectives, goals, strategies, expectations, intentions, projections, developments, future events, performance, underlying assumptions, and other statements that are other than statements of historical facts. Without limiting the foregoing, the words “believes”, “anticipates”, “plans”, “expects”, “estimates”, “projects”, “forecasts”, “may”, “assume”, “intend”, “will”, “continue”, “opportunity”, “predict”, “potential”, “future”, “guarantee”, “likely”, “target”, “indicate”, “would”, “could” and “should” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements are accompanied by such words. Such statements reflect management’s best judgment based on factors currently known but are subject to risks and uncertainties, which could cause actual results to differ materially from those anticipated. Such risks and uncertainties include, but are not limited to, the state of the economy and the financial services industry and other industries in which the Company’s clients operate, the Company’s ability to realize anticipated benefits from its acquisitions, including DST Systems, Inc., the effect of customer consolidation on demand for the Company’s products and services, the increasing focus of the Company’s business on the hedge fund industry, the variability of revenue as a result of activity in the securities markets, the ability to retain and attract clients, fluctuations in customer demand for the Company’s products and services, the intensity of competition with respect to the Company’s products and services, the exposure to litigation and other claims, terrorist activities and other catastrophic events, disruptions, attacks or failures affecting the Company’s software-enabled services, risks associated with the Company’s foreign operations, privacy concerns relating to the collection and storage of personal information, evolving regulations and increased scrutiny from regulators, the Company’s ability to protect intellectual property assets and litigation regarding intellectual property rights, delays in product development, investment decisions concerning cash balances, regulatory and tax risks, risks associated with the Company’s joint ventures, changes in accounting standards, risks related to the Company’s substantial indebtedness, the market price of the Company’s stock prevailing from time to time, and the risks discussed in the “Risk Factors” section of the Company’s most recent Annual Report on Form 10-K and Quarterly Report on Form 10-Q, which are on file with the Securities and Exchange Commission and can also be accessed on our website. Forward-looking statements speak only as of the date on which they are made and, except to the extent required by applicable securities laws, we undertake no obligation to update or revise any forward-looking statements.
About SS&C Technologies
SS&C is a global provider of services and software for the financial services and healthcare industries. Founded in 1986, SS&C is headquartered in Windsor, Connecticut, and has offices around the world. Some 20,000 financial services and healthcare organizations, from the world’s largest companies to small and mid-market firms, rely on SS&C for expertise, scale, and technology.
Follow SS&C on Twitter, LinkedIn and Facebook.
SS&C Technologies Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Comprehensive Income
(in millions, except per share data)
(unaudited)
Three Months Ended September 30,
Nine Months Ended September 30,
2024
2023
2024
2023
Revenues:
Software-enabled services
$
1,206.2
$
1,122.1
$
3,586.3
$
3,342.8
License, maintenance and related
259.6
243.8
766.0
748.4
Total revenues
1,465.8
1,365.9
4,352.3
4,091.2
Cost of revenues:
Software-enabled services
661.9
617.8
1,949.7
1,877.4
License, maintenance and related
99.7
93.7
292.9
281.3
Total cost of revenues
761.6
711.5
2,242.6
2,158.7
Gross profit
704.2
654.4
2,109.7
1,932.5
Operating expenses:
Selling and marketing
144.1
134.7
427.6
411.6
Research and development
131.3
117.7
380.9
355.5
General and administrative
103.7
95.6
315.6
290.7
Total operating expenses
379.1
348.0
1,124.1
1,057.8
Operating income
325.1
306.4
985.6
874.7
Interest expense, net
(109.6)
(120.6)
(338.9)
(350.5)
Other income (expense), net
9.3
(5.0)
16.5
15.3
Equity in earnings of unconsolidated affiliates, net
1.1
27.5
20.7
42.6
Loss on extinguishment of debt
(1.3)
(0.5)
(30.1)
(1.1)
Income before income taxes
224.6
207.8
653.8
581.0
Provision for income taxes
60.0
51.2
140.5
167.3
Net income
164.6
156.6
513.3
413.7
Net income attributable to noncontrolling interest
(0.2)
(0.6)
(1.0)
(1.0)
Net income attributable to SS&C common stockholders
$
164.4
$
156.0
$
512.3
$
412.7
Basic earnings per share attributable to SS&C common stockholders
$
0.67
$
0.63
$
2.08
$
1.66
Diluted earnings per share attributable to SS&C common stockholders
$
0.65
$
0.61
$
2.02
$
1.62
Basic weighted-average number of common shares outstanding
246.1
247.5
246.4
248.8
Diluted weighted-average number of common and common equivalent
shares outstanding
254.1
253.9
253.3
255.3
Net income
$
164.6
$
156.6
$
513.3
$
413.7
Other comprehensive income (loss), net of tax:
Foreign currency exchange translation adjustment
159.0
(113.0)
114.1
(4.8)
Change in defined benefit pension obligation
—
—
0.1
—
Total other comprehensive income (loss), net of tax
159.0
(113.0)
114.2
(4.8)
Comprehensive income
323.6
43.6
627.5
408.9
Comprehensive income attributable to noncontrolling interest
(0.2)
(0.6)
(1.0)
(1.0)
Comprehensive income attributable to SS&C common stockholders
$
323.4
$
43.0
$
626.5
$
407.9
SS&C Technologies Holdings, Inc. and Subsidiaries
Condensed Consolidated Balance Sheets
(in millions)
(unaudited)
September 30,
December 31,
2024
2023
Assets
Current assets:
Cash and cash equivalents
$
694.7
$
432.2
Funds receivable and funds held on behalf of clients
2,081.5
2,615.6
Accounts receivable, net
934.0
799.4
Contract asset
47.2
36.1
Prepaid expenses and other current assets
129.8
165.8
Restricted cash
3.5
2.4
Total current assets
3,890.7
4,051.5
Property, plant and equipment, net
309.4
315.3
Operating lease right-of-use assets
193.8
221.4
Investments
184.6
184.7
Unconsolidated affiliates
327.7
345.2
Contract asset
115.2
99.7
Goodwill
9,374.4
8,969.5
Intangible and other assets, net
4,042.6
3,915.2
Total assets
$
18,438.4
$
18,102.5
Liabilities and Equity
Current liabilities:
Current portion of long-term debt
$
47.1
$
51.5
Client funds obligations
2,081.6
2,615.6
Accounts payable
43.6
80.3
Income taxes payable
7.7
22.3
Accrued employee compensation and benefits
280.1
270.2
Interest payable
19.7
29.4
Other accrued expenses
275.9
232.3
Deferred revenue
464.0
470.3
Total current liabilities
3,219.7
3,771.9
Long-term debt, net of current portion
7,155.6
6,668.5
Operating lease liabilities
175.4
199.1
Other long-term liabilities
203.4
248.7
Deferred income taxes
796.2
816.6
Total liabilities
11,550.3
11,704.8
SS&C stockholders’ equity
6,814.1
6,339.6
Noncontrolling interest
74.0
58.1
Total equity
6,888.1
6,397.7
Total liabilities and equity
$
18,438.4
$
18,102.5
SS&C Technologies Holdings, Inc. and Subsidiaries
Condensed Consolidated Statements of Cash Flows
(in millions)
(unaudited)
Nine Months Ended September 30,
2024
2023
Cash flow from operating activities:
Net income
$
513.3
$
413.7
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization
504.3
500.4
Equity in earnings of unconsolidated affiliates, net
(20.7)
(42.6)
Distributions received from unconsolidated affiliates
13.1
21.2
Stock-based compensation expense
147.9
117.5
Net (gains) losses on investments
(2.5)
0.9
Amortization and write-offs of loan origination costs and original issue discounts
6.7
10.2
Loss on extinguishment of debt
30.1
1.1
Loss on sale or disposition of property and equipment
—
7.6
Deferred income taxes
(52.6)
(89.1)
Provision for credit losses
13.7
9.8
Changes in operating assets and liabilities, excluding effects from acquisitions:
Accounts receivable
(100.4)
(69.0)
Prepaid expenses and other assets
5.5
27.6
Contract assets
(25.3)
0.5
Accounts payable
(40.8)
(5.3)
Accrued expenses and other liabilities
(75.7)
(73.8)
Income taxes prepaid and payable
(8.9)
(16.3)
Deferred revenue
(5.7)
12.3
Net cash provided by operating activities
902.0
826.7
Cash flow from investing activities:
Cash paid for business acquisitions, net of cash acquired and asset acquisitions
(646.9)
(0.1)
Additions to property and equipment
(41.7)
(40.7)
Proceeds from sale of property and equipment
3.3
—
Additions to capitalized software
(149.7)
(140.9)
Investments in securities
—
(0.6)
Proceeds from sales / maturities of investments
0.3
7.7
Distributions received from unconsolidated affiliates
24.4
—
Collection of other non-current receivables
7.7
7.5
Net cash used in investing activities
(802.6)
(167.1)
Cash flow from financing activities:
Cash received from debt borrowings, net of original issue discount
5,545.0
275.0
Repayments of debt
(5,060.1)
(499.5)
Payment of deferred financing fees
(36.6)
—
Net decrease in client funds obligations
(952.2)
(163.7)
Proceeds from exercise of stock options
271.1
79.2
Withholding taxes paid related to equity award net share settlement
(20.3)
(1.7)
Purchases of common stock for treasury
(369.3)
(341.0)
Dividends paid on common stock
(182.6)
(160.9)
Proceeds from noncontrolling interests
14.9
—
Net cash used in financing activities
(790.1)
(812.6)
Effect of exchange rate changes on cash, cash equivalents and restricted cash
2.2
(4.2)
Net decrease in cash, cash equivalents and restricted cash
(688.5)
(157.2)
Cash, cash equivalents and restricted cash, beginning of period
2,998.6
1,337.6
Cash, cash equivalents and restricted cash and cash equivalents, end of period
$
2,310.1
$
1,180.4
Reconciliation of cash, cash equivalents and restricted cash and cash equivalents:
Cash and cash equivalents
$
694.7
$
447.6
Restricted cash and cash equivalents
3.5
2.3
Restricted cash and cash equivalents included in funds receivable and funds held on behalf of
clients
1,611.9
730.5
$
2,310.1
$
1,180.4
SS&C Technologies Holdings, Inc. and Subsidiaries
Disclosures Relating to Non-GAAP Financial Measures
Note 1. Reconciliation of Revenues to Adjusted Revenues
Adjusted revenues represents revenues adjusted to include a) amounts that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition and b) amounts that would have been recognized if not for adjustments to deferred revenue and retained earnings related to the adoption of ASC 606. Adjusted revenues is presented because we use this measure to evaluate performance of our business against prior periods and believe it is a useful indicator of the underlying performance of our business. Adjusted revenues is not a recognized term under generally accepted accounting principles (“GAAP”). Adjusted revenues does not represent revenues, as that term is defined under GAAP, and should not be considered as an alternative to revenues as an indicator of our operating performance. Adjusted revenues as presented herein is not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted revenues to revenues, the GAAP measure we believe to be most directly comparable to adjusted revenues.
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in millions)
2024
2023
2024
2023
Revenues
$
1,465.8
$
1,365.9
$
4,352.3
$
4,091.2
ASC 606 adoption impact
(0.7)
(0.8)
(2.2)
(2.5)
Purchase accounting adjustments impact on revenue
1.7
1.6
4.9
4.8
Adjusted revenues
$
1,466.8
$
1,366.7
$
4,355.0
$
4,093.5
The following is a breakdown of software-enabled services and license, maintenance and related revenues and adjusted software-enabled services and license, maintenance and related revenues.
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in millions)
2024
2023
2024
2023
Software-enabled services
$
1,206.2
$
1,122.1
$
3,586.3
$
3,342.8
License, maintenance and related
259.6
243.8
766.0
748.4
Total revenues
$
1,465.8
$
1,365.9
$
4,352.3
$
4,091.2
Software-enabled services
$
1,207.3
$
1,123.1
$
3,589.1
$
3,345.4
License, maintenance and related
259.5
243.6
765.9
748.1
Total adjusted revenues
$
1,466.8
$
1,366.7
$
4,355.0
$
4,093.5
Note 2. Reconciliation of Operating Income to Adjusted Operating Income
Adjusted operating income represents operating income adjusted for amortization of intangible assets, stock-based compensation, purchase accounting adjustments for deferred revenue and related costs, ASC 606 adoption impact and other expenses. Adjusted operating income is presented because we use this measure to evaluate performance of our business and believe it is a useful indicator of our underlying performance. Adjusted operating income is not a recognized term under GAAP. Adjusted operating income does not represent operating income, as that term is defined under GAAP, and should not be considered as an alternative to operating income as an indicator of our operating performance. Adjusted operating income as presented herein is not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation between adjusted operating income and operating income, the GAAP measure we believe to be most directly comparable to adjusted operating income.
Three Months Ended
September 30,
Nine Months Ended
September 30,
(in millions)
2024
2023
2024
2023
Operating income
$
325.1
$
306.4
$
985.6
$
874.7
Amortization of intangible assets
152.4
150.6
449.1
445.3
Stock-based compensation
52.2
42.1
147.9
117.5
Purchase accounting adjustments (1)
3.4
3.6
9.5
12.0
ASC 606 adoption impact
(0.7)
(0.8)
(2.0)
(2.3)
Acquisition related (2)
1.6
2.4
2.7
7.8
Facilities and workforce restructuring
14.0
13.8
33.6
42.5
Other (3)
1.7
0.2
7.2
0.8
Adjusted operating income
$
549.7
$
518.3
$
1,633.6
$
1,498.3
Adjusted operating income attributable to noncontrolling interest (4)
(0.9)
(0.9)
(3.1)
(2.1)
Adjusted operating income attributable to SS&C common
stockholders
$
548.8
$
517.4
$
1,630.5
$
1,496.2
(1)
Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition, (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to decrease depreciation expense by the amount that would not have been recognized if property, plant and equipment were not adjusted to fair value at the date of acquisition.
(2)
Acquisition related includes costs related to both current acquisitions and the resolution of pre-acquisition matters for prior period acquisitions.
(3)
Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance.
(4)
In 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted operating income attributable to noncontrolling interest represents adjusted operating income based on the ownership interest retained by the respective noncontrolling parties.
Note 3. Reconciliation of Net Income to EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA
EBITDA represents net income before interest expense, income taxes, depreciation and amortization. Consolidated EBITDA, defined under our Credit Agreement entered into in April 2018, as amended, is used in calculating covenant compliance, and is EBITDA adjusted for certain items. Consolidated EBITDA is calculated by subtracting from or adding to EBITDA items of income or expense described below. Adjusted Consolidated EBITDA is calculated by subtracting acquired EBITDA (as defined below) from Consolidated EBITDA. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are presented because we use these measures to evaluate performance of our business and believe them to be useful indicators of an entity’s debt capacity and its ability to service debt. EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA are not recognized terms under GAAP and should not be considered in isolation or as alternatives to operating income, net income or cash flows from operating activities as indicators of our operating performance. These measures are not necessarily comparable to similarly titled measures by other companies. The following is a reconciliation of EBITDA, Consolidated EBITDA and Adjusted Consolidated EBITDA to net income.
Three Months Ended
September 30,
Nine Months Ended
September 30,
Twelve
Months
Ended
September 30,
(in millions)
2024
2023
2024
2023
2024
Net income
$
164.6
$
156.6
$
513.3
$
413.7
$
708.3
Interest expense, net
109.6
120.6
338.9
350.5
458.3
Provision for income taxes
60.0
51.2
140.5
167.3
222.2
Depreciation and amortization
171.3
168.5
504.3
500.4
674.4
EBITDA
505.5
496.9
1,497.0
1,431.9
2,063.2
Stock-based compensation
52.2
42.1
147.9
117.5
189.8
Acquired EBITDA and cost savings (1)
0.8
—
19.4
—
34.5
Loss on extinguishment of debt
1.3
0.5
30.1
1.1
31.1
Equity in earnings of unconsolidated affiliates, net
(1.1)
(27.5)
(20.7)
(42.6)
(78.2)
Purchase accounting adjustments (2)
1.9
2.4
5.7
6.7
8.3
ASC 606 adoption impact
(0.7)
(0.8)
(2.0)
(2.3)
(2.7)
Foreign currency translation (gains) losses
(4.2)
2.5
1.6
3.7
(2.3)
Investment (gains) losses (3)
(5.3)
0.5
(17.3)
(13.7)
(22.5)
Facilities and workforce restructuring
13.9
13.8
33.6
42.5
47.9
Acquisition related (4)
1.8
3.9
2.7
(1.3)
3.9
Other (5)
1.8
0.5
6.4
3.8
10.0
Consolidated EBITDA
$
567.9
$
534.8
$
1,704.4
$
1,547.3
$
2,283.0
Acquired EBITDA and cost savings (1)
(0.8)
—
(19.4)
—
(34.5)
Adjusted Consolidated EBITDA
$
567.1
$
534.8
$
1,685.0
$
1,547.3
$
2,248.5
Adjusted Consolidated EBITDA attributable to noncontrolling
interest (6)
(0.9)
(0.9)
(3.1)
(2.1)
(4.0)
Adjusted Consolidated EBITDA attributable to SS&C common
stockholders
$
566.2
$
533.9
$
1,681.9
$
1,545.2
$
2,244.5
(1)
Acquired EBITDA reflects the EBITDA impact of significant businesses that were acquired during the period as if the acquisition occurred at the beginning of the period, as well as cost savings enacted in connection with acquisitions.
(2)
Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisitions (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to increase or decrease rent expense by the amount that would have been recognized if lease obligations were not adjusted to fair value at the date of acquisitions.
(3)
Investment gains includes unrealized fair value adjustments of investments and dividend income received on investments.
(4)
Acquisition related includes costs related to both current acquisitions and the resolution of pre-acquisition matters for prior period acquisitions.
(5)
Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance.
(6)
In 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted Consolidated EBITDA attributable to noncontrolling interest represents adjusted Consolidated EBITDA based on the ownership interest retained by the respective noncontrolling parties.
Note 4. Reconciliation of Net Income to Adjusted Net Income and Diluted Earnings Per Share Attributable to SS&C to Adjusted Diluted Earnings Per Share Attributable to SS&C
Adjusted net income and adjusted diluted earnings per share attributable to SS&C represent net income and earnings per share attributable to SS&C before amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments and other items. We consider adjusted net income and adjusted diluted earnings per share attributable to SS&C to be important to management and investors because they represent our operational performance exclusive of the effects of amortization of intangible assets and deferred financing costs, stock-based compensation, purchase accounting adjustments, loss on extinguishment of debt and other items, that are not operational in nature or comparable to those of our competitors. Adjusted net income and adjusted diluted earnings per share are not recognized terms under GAAP. Adjusted net income and adjusted diluted earnings per share do not represent net income or diluted earnings per share, as those terms are defined under GAAP, and should not be considered as alternatives to net income or diluted earnings per share as indicators of our operating performance. Adjusted net income and adjusted diluted earnings per share attributable to SS&C as presented herein are not necessarily comparable to similarly titled measures presented by other companies. Below is a reconciliation of adjusted net income and adjusted diluted earnings per share attributable to SS&C to net income and diluted earnings per share attributable to SS&C, the GAAP measures we believe to be most directly comparable to adjusted net income and adjusted diluted earnings per share.
Three Months Ended
September 30,
Nine Months Ended September 30,
(in millions, except per share data)
2024
2023
2024
2023
GAAP – Net income
$
164.6
$
156.6
$
513.3
$
413.7
Amortization of intangible assets
152.4
150.6
449.1
445.3
Amortization of deferred financing costs and original issue discount
1.4
3.3
6.7
10.2
Stock-based compensation
52.2
42.1
147.9
117.5
Loss on extinguishment of debt
1.3
0.5
30.1
1.1
Purchase accounting adjustments (1)
3.4
3.6
9.5
12.0
ASC 606 adoption impact
(0.7)
(0.8)
(2.0)
(2.3)
Equity in earnings of unconsolidated affiliates, net
(1.1)
(27.5)
(20.7)
(42.6)
Foreign currency translation (gains) losses
(4.2)
2.5
1.6
3.7
Investment (gains) losses (2)
(3.1)
2.7
(2.5)
0.9
Facilities and workforce restructuring
13.9
13.8
33.6
42.5
Acquisition related (3)
1.8
3.9
2.7
(1.3)
Other (4)
1.8
0.8
6.3
4.7
Income tax effect (5)
(55.4)
(53.6)
(201.7)
(137.6)
Adjusted net income
$
328.3
$
298.5
$
973.9
$
867.8
Adjusted net income attributable to noncontrolling interest (6)
(1.2)
(1.2)
(3.6)
(2.3)
Adjusted net income attributable to SS&C common stockholders
$
327.1
$
297.3
$
970.3
$
865.5
Adjusted diluted earnings per share attributable to SS&C common
stockholders
$
1.29
$
1.17
$
3.83
$
3.39
GAAP diluted earnings per share attributable to SS&C common
stockholders
$
0.65
$
0.61
$
2.02
$
1.62
Diluted weighted-average shares outstanding
254.1
253.9
253.3
255.3
(1)
Purchase accounting adjustments include (a) an adjustment to increase revenues by the amount that would have been recognized if deferred revenue were not adjusted to fair value at the date of acquisition, (b) an adjustment to increase personnel and commissions expense by the amount that would have been recognized if prepaid commissions and deferred personnel costs were not adjusted to fair value at the date of the acquisitions and (c) an adjustment to decrease depreciation expense by the amount that would not have been recognized if property, plant and equipment were not adjusted to fair value at the date of acquisition.
(2)
Investment gains includes unrealized fair value adjustments of investments. In prior periods, investment gains also included dividend income received on investments. Prior period amounts have been revised for consistent presentation.
(3)
Acquisition related includes costs related to both current acquisitions and the resolution of pre-acquisition matters for prior period acquisitions.
(4)
Other includes additional expenses and income that are permitted to be excluded per the terms of our Credit Agreement from Consolidated EBITDA, a financial measure used in calculating our covenant compliance.
(5)
An estimated normalized effective tax rate of approximately 26% for the three and nine months ended September 30, 2024 and 2023 has been used to adjust the provision for income taxes for the purpose of computing adjusted net income.
(6)
In 2021, we entered into a joint venture named DomaniRx, LLC in which we are the majority interest holder and primary beneficiary. As such, we consolidate DomaniRx, LLC as a variable interest entity. Adjusted net income attributable to noncontrolling interest represents adjusted net income based on the ownership interest retained by the respective noncontrolling parties.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ssc-technologies-releases-q3-2024-earnings-results-302286556.html
SOURCE SS&C
You may like
Technology
Quarterhill Awarded High-Speed Weigh-In-Motion Prescreening Contract in Belgium
Published
34 minutes agoon
January 10, 2025By
The new WIM station will assist Brussels Mobility in achieving its goals of improving road safety and creating a fair regulatory environment by reducing the number of overloaded vehicles on the roads of the Brussels region.Traffic data provided by the system will support Brussels Mobility’s mission to foster economic growth and improve quality of life through the development of transport infrastructure.
TORONTO, Jan. 10, 2025 /PRNewswire/ – Quarterhill Inc. (“Quarterhill” or the “Company”) (TSX: QTRH) (OTCQX: QTRHF), announced today a contract to provide weigh-in-motion (“WIM”) technology to Brussels Mobility through a joint project with Belgium-based technology integrator Jacops NV (“Jacops”). Quarterhill will be responsible for the design and supply of the WIM subsystem, technical support, and training. Quarterhill will also provide Jacops with the software necessary for commercial vehicle monitoring and enforcement.
Quarterhill will supply the WIM system for the Brussels-Capital Region weigh station, which will be used to pre-select overloaded vehicles for enforcement. The dynamic weighing station will promote and improve the efficiency of inspections by screening vehicles at highway speeds in advance of the law enforcement inspection site. In addition, the weigh station will generate data that provides an accurate, real-time picture of the vehicles on the E19 highway.
The system’s goal is to reduce the number of overloaded vehicles on the Brussels Region’s roads. Overloading causes many problems, such as rapid road deterioration, more serious accidents, and unfair competition between transport companies. Quarterhill’s technology mitigates these issues by screening for overweight vehicles while optimizing the use of enforcement resources.
“We are excited at the prospect of introducing our advanced enforcement technology to Brussels Mobility and expanding our presence in Europe,” said Chuck Myers, CEO of Quarterhill. “Together with Jacops, we will deploy a state-of-the-art high-speed WIM system that will make Belgian roads safer and more sustainable. We have a longstanding relationship with Jacops as a customer for our microwave sensor products, and this project demonstrates how having a broad portfolio of traffic technologies and established relationships with traffic system integrators leads to further opportunities.”
The weigh station will monitor four lanes of one-way traffic on the highway and record data on vehicle classification and vehicle tax without impeding traffic. An overview camera provides images to help enforcement personnel clearly identify vehicles flagged by the system. An Automated Number Plate Reader system will photograph, recognize, store, process, and transmit the number plates of vehicles approaching the dynamic weighing station.
Quarterhill’s iSINC WIM controller was selected for the project as it offers preselection of overweight vehicles, creates comprehensive vehicle records, classifies vehicles, and meets the desired standards for continual uptime monitoring and ease of service. iSINC’s versatility allows it to control a wide array of sensors, cameras, dimensioning systems, communication systems, and custom equipment.
WIM sensors that comply with the accuracies outlined in the Nmi International WIM standard Specification and test procedures for WIM Systems will be installed at the site. The WIM sensors meet the lane width specifications and provide high durability, stable output over time, and IP68 water resistance.
Quarterhill will advise Jacops on the design and placement of the WIM system components to ensure optimal operation, including onsite technical support for installation, testing, and initial calibration. Quarterhill will also provide Jacops with thorough training on the WIM components and system calibration. Over the 2-year warranty period, Quarterhill will provide remote diagnostics and technical support to ensure continuous uptime and optimal performance.
“This project shows that Quarterhill’s technology is well suited to the precise needs of European agencies. We are set to elevate road safety and integrity in the region, reinforcing our expanding footprint in this important market,” stated Heimo Haub, Managing Director, Quarterhill Europe.
About Quarterhill
Quarterhill is a leading provider of tolling and enforcement solutions in the Intelligent Transportation System (ITS) industry. Our goal is technology-driven global leadership in ITS, via organic growth of our tolling and enforcement businesses, and by continuing an acquisition-oriented investment strategy that capitalizes on attractive growth opportunities within ITS and its adjacent markets. Quarterhill is listed on the TSX under the symbol QTRH and on the OTCQX Best Market under the symbol QTRHF. For more information: www.quarterhill.com.
Forward-looking Information
This news release contains forward-looking information and forward-looking statements within the meaning of applicable Canadian securities laws (collectively, “forward-looking statements”). Such forward-looking statements relate to future events, conditions or future financial performance of Quarterhill based on future economic conditions and courses of action. All statements other than statements of historical fact may be forward-looking statements. Such forward-looking statements are often, but not always, identified by the use of any words such as “seek”, “anticipate”, “budget”, ”plan”, “goal”, “expect” and similar expressions.
Forward-looking statements involve known and unknown risks, assumptions, uncertainties and other factors that may cause actual results or events to differ materially from those anticipated in such forward-looking statements. Material risk factors that could cause actual results to differ materially from the forward-looking statements contained in this news release include, among others, demand for Quarterhill’s products and services; general economic and market conditions; competition; risks relating to technological advances and cyber-security; and other risks set forth in the Company’s most recent annual information form available on SEDAR+ at www.sedarplus.ca. The Company believes the expectations reflected in the forward-looking statements are reasonable, but no assurance can be given that these expectations will prove to be correct and such forward-looking statements included in this news release should not be unduly relied upon. Material factors and assumptions used to develop the forward-looking statements contained in this news release include, among others: Quarterhill’s ability to execute on its business plan; demand for Quarterhill’s products and services; operating assumptions; and financial projections and cost estimates. Quarterhill has no intention, and undertakes no obligation, to update or revise any forward-looking statements, whether as a result of new information, future events or otherwise, except as required by law.
View original content:https://www.prnewswire.com/news-releases/quarterhill-awarded-high-speed-weigh-in-motion-prescreening-contract-in-belgium-302347610.html
SOURCE Quarterhill
Technology
ez1099 2024 Edition Tax Preparation Software for 2025 Tax Season Is Available for Electronic Filing
Published
34 minutes agoon
January 10, 2025By
REDMOND, Wash., Jan. 10, 2025 /PRNewswire/ — Designed for US business owners, tax professionals and entrepreneurs, the latest ez1099 tax form software from Halfpricesoft.com is easy to navigate and streamline processing unlimited forms for multiple companies for one flat rate. The latest edition of ez1099 supports paper form printing, pdf printing and efile feature. It also comes with a recipient data import feature from the spreadsheet and QuickBooks IIF file.
“ez1099 2024 software is now available for business owners and tax professionals to print and file 1098’s and 1099’s, seamlessly.” Dr. Ge, Founder of Halfpricesoft.com, says.
ez1099 software streamlines the preparation, printing, and e-filing of essential IRS forms, including W2G, 1097BTC, various 1098 forms (1098, 1098C, 1098E, 1098F, 1098Q, 1098T), numerous 1099 forms (1099A, 1099B, 1099C, 1099CAP, 1099DIV, 1099G, 1099INT, 1099K, 1099LTC, 1099MISC, 1099NEC, 1099OID, 1099PATR, 1099Q, 1099QA, 1099R, 1099S, 1099SB, 1099SA), 5498 forms (5498, 5498ESA, 5498QA, 5498SA), as well as 8935, 3921, 3922, and 1096 forms.
Cost is only $79 per installation for the basic version of ez1099 Software or $139 per installation for the advanced version with bulk printing feature, import feature, PDF file creation and electronic filing capability. Also offered in a network version for two or more installations starting at $199 to enable sharing data between computers or offices.
ez1099 is compatible with Windows 11, 10, and 8. It can also run on Windows Vista system, 7, and MAC machines (Mac can run the system only if installed with Bootcamp).
The features in the latest version ez1099 software include but are not limited to:
electronically file unlimited forms to the IRS with one flat rateez1099 blank paper prints out recipient copiesPrint in bulk for faster processingQuick data importing featureCustomers can save even more time by compiling and saving form data for later use and modificationSupport unlimited accounts and unlimited recipients at no additional chargeGo green with optional PDF document converting and e-file (electronic filing) featuresFeature to process correction forms included
Starting at $79.00 for the print and mail version and $139.00 to electronically file. Halfpricesoft.com welcomes all clients to begin the no obligation thirty-day test drive today at https://www.halfpricesoft.com/1099_software.asp#purchase
About halfpricesoft.com
Halfpricesoft.com is a leading provider of small to midsize business software, including online and desktop payroll software, online employee attendance tracking software, accounting software, in-house business and personal check printing software, W2, software, 1099 software, 1095 ACA form software and ezACH direct deposit software. Software from halfpricesoft.com is trusted by thousands of customers for over 20 years and will assist business owners simplify payroll processing and streamline business management.
View original content to download multimedia:https://www.prnewswire.com/news-releases/ez1099-2024-edition-tax-preparation-software-for-2025-tax-season-is-available-for-electronic-filing-302340859.html
SOURCE Halfpricesoft.com
Technology
The New York Stem Cell Foundation Research Institute Enters Agreement to Accelerate Precision Drug Discovery for Neurodegenerative Disease
Published
34 minutes agoon
January 10, 2025By
Partnership Will Harness NYSCF’s Automated Cell Culture Systems and Artificial Intelligence Capabilities to Study Disease at an Unprecedented Cellular Level
NEW YORK, Jan. 10, 2025 /PRNewswire/ — The New York Stem Cell Foundation (NYSCF) Research Institute today announced they have entered into an agreement with Janssen Research & Development, LLC, a Johnson & Johnson company, to use NYSCF’s AI-powered platform for drug discovery to target neurodegenerative disease. This initiative brings together NYSCF’s advanced robotic systems for stem cell research and J&J’s expertise in drug discovery and data science to unlock novel disease insights and accelerate the development of more effective and tailored treatments.
NYSCF has developed proprietary automation technology that enables large-scale, reproducible disease modeling and drug screening using patient-derived stem cells. By combining high-content cell imaging with machine learning-driven analysis, NYSCF’s platform can reveal previously undiscovered disease phenotypes and therapeutic targets leading to the development of novel therapeutic approaches. This versatile platform is adaptable to a wide range of cell types and diseases, making it uniquely positioned to advance precision medicine for patients.
“This work with Johnson & Johnson allows us to integrate our cutting-edge stem cell automation and AI platform with their deep expertise in therapeutic development,” said Jennifer J. Raab, President and CEO of NYSCF. “Together, we look forward to accelerating the discovery of innovative treatments for patients affected by devastating neurodegenerative disease.”
About The New York Stem Cell Foundation Research Institute
The New York Stem Cell Foundation (NYSCF) Research Institute is an independent non-profit organization accelerating cures and better treatments for patients through stem cell research. The NYSCF Research Institute is an acknowledged world leader in stem cell research and in the development of pioneering stem cell technologies, including the NYSCF Global Stem Cell Array®, which is used to create cell lines for laboratories around the globe. NYSCF focuses on translational research in an accelerator model designed to overcome barriers that slow discovery and replace silos with collaboration. For more information, visit nyscf.org.
CONTACTS:
David McKeon
212-365-7440
dmckeon@nyscf.org
Chris Taylor
chris@christaylorpr.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/the-new-york-stem-cell-foundation-research-institute-enters-agreement-to-accelerate-precision-drug-discovery-for-neurodegenerative-disease-302347569.html
SOURCE The New York Stem Cell Foundation
Quarterhill Awarded High-Speed Weigh-In-Motion Prescreening Contract in Belgium
ez1099 2024 Edition Tax Preparation Software for 2025 Tax Season Is Available for Electronic Filing
The New York Stem Cell Foundation Research Institute Enters Agreement to Accelerate Precision Drug Discovery for Neurodegenerative Disease
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
Peloton Unveils Holiday 2022 Creative Campaign Highlighting How Motivation Transcends Beyond the Workout
These ’90s fashion trends are making a comeback in 2017
Why You Should Build on #NEAR – Co-founder Illia Polosukhin at CV Labs
Whiteboard Series with NEAR | Ep: 45 Joel Thorstensson from ceramic.network
NEAR End of Year Town Hall 2021: The Open Web World, MetaBUILD 2 Hackathon and 2021 recap
Trending
-
Technology5 days ago
Sansui’s Award-Winning AI Gaming Monitor Blends Health and Performance Innovation at CES 2025
-
Technology5 days ago
“Rock a New Era”: Roborock Revolutionises Smart Home Cleaning at CES 2025 with robotic arm equipped Saros Z70
-
Coin Market3 days ago
Toyota’s AI and Robotics-powered ‘Woven City’ set to open this year
-
Technology5 days ago
EcoFlow Debuts AI-Powered OASIS at CES 2025, Maximizing Energy Savings and Extreme Weather Prep
-
Coin Market5 days ago
Mining company MARA lent out 7,377 BTC to third parties in 2024
-
Technology4 days ago
Amorepacific Named CES 2025 Innovation Award Honoree
-
Technology4 days ago
NIKON EXHIBITS AT CES 2025
-
Technology4 days ago
Tencent Cloud Recognized Again in the Gartner® “Competitive Landscape: Video Platform Services” Report, solidifying its Pioneering Position in the Asia-Pacific Market